[Serum calcium levels at first renal replacement therapy and patients survival].
In K/DOQI guideline, albumin adjusted serum calcium concentrations between 8.4 to 9.5 mg/dL and serum phosphorus concentrations between 3.5 to 5.5 mg/dL are recommended. But without clinical symptoms relating to hypocalcemia, medication for increasing serum calcium levels is not needed even less than 8.4 mg/dL. To clarify this guideline, we examined the data of 271 patients who started dialysis at Shinrakuen Hospital, their medication before renal replacement therapy and life prognosis. Medication made higher serum calcium concentrations (p< 0.005) at first renal replacement therapy. Concerning serum calcium concentrations, the lower group (<8.4 mg/dL) showed significantly better prognosis than the middle group (8.4 to 9.5 mg/dL) and the higher group (>9.5 mg/dL) (p< 0.05). When serum calcium levels were adjusted for the level of serum albumin, this tendency was stronger (p< 0.0001). We concluded that although serum calcium concentrations might not need control, nutritional states are far more important before starting dialysis.
Osawa
Yutaka
Y
Kidney Center of Shinrakuen Hospital.
Aoike
Ikuo
I
Sakurabayashi
Tai
T
Miyazaki
Shigeru
S
Yuasa
Yasuko
Y
Suzuki
Masashi
M
D015415:Biomarkers / Q000097:blood; D002118:Calcium / Q000008:administration & dosage / Q000097:blood*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D008297:Male; D009752:Nutritional Status; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D017582:Renal Replacement Therapy / Q000009:adverse effects; D012709:Serum Albumin / Q000378:metabolism; D014807:Vitamin D / Q000008:administration & dosage
D015415:Biomarkers; D010281:Parathyroid Hormone; D012709:Serum Albumin; D014807:Vitamin D; D010758:Phosphorus; D002118:Calcium